Administering tranexamic acid both intravenously and injected at the surgical site reduced blood loss by 37%, compared to IV alone, following total knee replacement.

‘Administering tranexamic acid both intravenously (IV) and injected at the surgical site reduced blood loss by 37%, compared to IV alone, following total knee replacement.’

The patient group receiving TXA IV and IA had a 37% greater reduction in blood loss at 24 and 48 hours post-surgery, compared to the patients who received TXA IV only. No thromboembolic complications were observed in any of the patients within 90 days postoperatively. One patient in the IV-only group required a postoperative blood transfusion. 




"The clinically relevant reduction in blood loss was achieved simply, cost-effectively, and without compromising safety, potentially reducing the negative effects of blood loss on early functional recovery, the number of blood transfusions and related costs," said study author Henrik Husted, associate professor and head of orthopedics at Copenhagen University Hospital Hvidore in Copenhagen, Denmark.
Source-Eurekalert